TRIN News

Trinity Capital Inc. Provides $20 Million in Growth Capital to Emboline, Inc. to Advance Interventional Heart Procedure Technology

Emboline, Inc. Secures $20 Million in Growth Capital from Trinity Capital Inc. to Support Commercialization of the Emboliner® Embolic Protection System to Minimize Stroke Risk From TAVR

Emboline, Inc. Secures $20 Million in Growth Capital from Trinity Capital Inc. to Support Commercialization of the Emboliner® Embolic Protection System to Minimize Stroke Risk From TAVR USA - English USA - English

Trinity Capital Inc. Provides $35 Million in Growth Capital to Neuros Medical, Inc. to Scale Pain Management Therapy Adoption

Trinity Capital Inc. Provides $50 Million in Growth Capital to Dwelly, Scaling UK Property-Management Marketplace

Trinity Capital Reports Fourth Quarter and Full Year 2025 Financial Results

Form 8-K

Trinity Capital Inc. Closes Deal with Motorway, Providing £25m to Fuel Further UK Growth

Morningstar DBRS Confirms Trinity Capital's Investment Grade Rating and Revises the Trend to Positive

Trinity Capital Announces Transition to Monthly Regular Dividends and Declares Cash Distribution of $0.51 per Share for the Fourth Quarter of 2025